Barclays PLC set a CHF 295 price target on Roche Holding Ltd. (VTX:ROG) in a research note released on Wednesday. The brokerage currently has a buy rating on the healthcare company’s stock.

A number of other equities analysts have also recently issued reports on ROG. UBS AG set a CHF 260 price objective on shares of Roche Holding and gave the company a neutral rating in a research note on Thursday, July 6th. Kepler Capital Markets set a CHF 230 price objective on shares of Roche Holding and gave the company a neutral rating in a research note on Monday, September 11th. Berenberg Bank set a CHF 273 price objective on shares of Roche Holding and gave the company a buy rating in a research note on Tuesday, August 15th. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on shares of Roche Holding and gave the company a buy rating in a research note on Tuesday, August 8th. Finally, Deutsche Bank AG set a CHF 255 price target on shares of Roche Holding and gave the stock a neutral rating in a research report on Monday, September 11th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of CHF 267.53.

Roche Holding (VTX:ROG) opened at 243.20 on Wednesday. The company has a market cap of CHK 207.51 billion and a PE ratio of 21.59. The firm has a 50 day moving average price of CHK 243.57 and a 200 day moving average price of CHK 252.42. Roche Holding has a 12-month low of CHK 218.30 and a 12-month high of CHK 273.00.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/17/barclays-plc-reiterates-chf-295-price-target-for-roche-holding-ltd-rog.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.